BioSyent Inc. (OTCMKTS:BIOYF – Get Free Report) was the recipient of a large growth in short interest during the month of June. As of June 30th, there was short interest totalling 1,400 shares, a growth of 600.0% from the June 15th total of 200 shares. Based on an average trading volume of 1,500 shares, the days-to-cover ratio is currently 0.9 days.
BioSyent Stock Up 0.1 %
OTCMKTS BIOYF traded up $0.01 during trading on Thursday, hitting $7.50. The stock had a trading volume of 100 shares, compared to its average volume of 2,556. BioSyent has a one year low of $5.54 and a one year high of $7.76. The stock has a 50 day simple moving average of $6.86 and a 200 day simple moving average of $6.57.
BioSyent Cuts Dividend
The firm also recently declared a dividend, which was paid on Saturday, June 15th. Investors of record on Monday, June 3rd were paid a dividend of $0.0331 per share. This represents a dividend yield of 2.02%. The ex-dividend date was Friday, May 31st.
BioSyent Company Profile
BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.
Further Reading
- Five stocks we like better than BioSyent
- How to Capture the Benefits of Dividend Increases
- Sales Breakout Sends This Semiconductor Stock to Record High
- Conference Calls and Individual Investors
- Surprise Buying Opportunity on This Dividend Aristocrat
- How to Invest in the FAANG Stocks
- New Theme Park Powerhouse: Merger Creates Industry-Leading Stock
Receive News & Ratings for BioSyent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSyent and related companies with MarketBeat.com's FREE daily email newsletter.